Switch to:

Arena Pharmaceuticals EV-to-EBIT

: 2.88 (As of Today)
View and export this data going back to 2000. Start your Free Trial

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Arena Pharmaceuticals's Enterprise Value is USD 1,722.1 Mil. Arena Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Jun. 2019 was USD 598.4 Mil. Therefore, Arena Pharmaceuticals's EV-to-EBIT for today is 2.88.

NAS:ARNA' s EV-to-EBIT Range Over the Past 10 Years
Min: -219.7   Max: 3.6
Current: 2.88

-219.7
3.6

During the past 13 years, the highest EV-to-EBIT of Arena Pharmaceuticals was 3.60. The lowest was -219.70. And the median was -7.60.

NAS:ARNA's EV-to-EBIT is ranked higher than
76% of the 272 Companies
in the Biotechnology industry.

( Industry Median: 17.63 vs. NAS:ARNA: 2.88 )

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Arena Pharmaceuticals's Enterprise Value for the quarter that ended in Jun. 2019 was USD 1,956.1 Mil. Arena Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Jun. 2019 was USD 598.4 Mil. Arena Pharmaceuticals's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2019 was 30.59%.


Arena Pharmaceuticals EV-to-EBIT Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Arena Pharmaceuticals Annual Data
Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
EV-to-EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -12.54 -3.59 -55.38 -12.33 -11.48

Arena Pharmaceuticals Quarterly Data
Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19
EV-to-EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.07 -16.67 -11.48 1.85 3.27

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Arena Pharmaceuticals EV-to-EBIT Distribution

* The bar in red indicates where Arena Pharmaceuticals's EV-to-EBIT falls into.



Arena Pharmaceuticals EV-to-EBIT Calculation

Arena Pharmaceuticals's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1722.093/598.377
=2.88

Arena Pharmaceuticals's current Enterprise Value is USD 1,722.1 Mil.
Arena Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Jun. 2019 was -32.925 (Sep. 2018 ) + -40.225 (Dec. 2018 ) + 731.708 (Mar. 2019 ) + -60.181 (Jun. 2019 ) = USD 598.4 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Arena Pharmaceuticals  (NAS:ARNA) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it consider the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Arena Pharmaceuticals's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2019 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2019 =EBIT / Enterprise Value (Q: Jun. 2019 )
=598.377/1956.14239
=30.59 %

Arena Pharmaceuticals's Enterprise Value for the quarter that ended in >Jun. 2019 was USD 1,956.1 Mil.
Arena Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Jun. 2019 was -32.925 (Sep. 2018 ) + -40.225 (Dec. 2018 ) + 731.708 (Mar. 2019 ) + -60.181 (Jun. 2019 ) = USD 598.4 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Arena Pharmaceuticals EV-to-EBIT Related Terms


Arena Pharmaceuticals EV-to-EBIT Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}